Skip to main content
SpringerLink
Log in

Technology commercialization firms float in UK—but not elsewhere

  • News
  • Published:

From Nature Biotechnology

View current issue Submit your manuscript

British technology companies are uniquely turning to public markets rather than private investors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Author information

Authors and Affiliations

  1. London

    Nuala Moran

Authors
  1. Nuala Moran
    View author publications

    You can also search for this author in PubMed Google Scholar

Related links

Related links

Related links in Nature Research

Public sector seeks to bridge 'valley of death'

Web links

Amphion Innovations

Biofusion

IP Group

IPSO Ventures

Sigma Capital Group

Rights and permissions

Reprints and permissions

About this article

Cite this article

Moran, N. Technology commercialization firms float in UK—but not elsewhere. Nat Biotechnol 25, 697–698 (2007). https://doi.org/10.1038/nbt0707-697

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt0707-697

  • Springer Nature America, Inc.

Search

Navigation